ARTICLE | Company News
PTAB to review Biogen's Tecfidera patent
February 15, 2019 7:59 PM UTC
The U.S. Patent Trial and Appeal Board will review a patent held by Biogen Inc. (NASDAQ:BIIB) covering methods of treating multiple sclerosis with Tecfidera dimethyl fumarate. Mylan N.V. (NASDAQ:MYL) filed the inter partes review (IPR) petition challenging the patent in July 2018...